SCHEMBL25035952

SCHEMBL25035952

c1ccc(-c2ccc(-c3nc(-c4cccc(-c5ccccc5)c4)nc(-c4ccc5c(c4)C4(c6cc7ccccc7cc6-5)C5CC6CC(C5)CC4C6)n3)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.36
KMT2A Q03164 5/20 0.36
ALDH1A1 P00352 3/20 0.36
MAPT P10636 3/20 0.36
HPGD P15428 3/20 0.36
KDM4E B2RXH2 2/20 0.35
LMNA P02545 2/20 0.35
GLA P06280 1/20 0.35
GP6 Q9HCN6 2/20 0.35
PDK2 Q15119 4/20 0.34
HTT P42858 1/20 0.33
HSD11B1 P28845 1/20 0.33
FFAR4 Q5NUL3 1/20 0.32
THRB P10828 1/20 0.31
RECQL P46063 1/20 0.31
NR2E1 Q9Y466 1/20 0.31
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
NTSR1 P30989 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25038139 1.00 MEN1 (0.36) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL25038115 0.99 MEN1 (0.37) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL25037838 0.96 MEN1 (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL25038130 0.96 MEN1 (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL25038053 0.95 MEN1 (0.39) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL25038196 0.95 PDK2 (0.34) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL25037669 0.95 PDK2 (0.34) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL24618078 0.94 GP6 (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL25588733 0.94 GP6 (0.38) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL25035956 0.93 GP6 (0.35) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691952-B2 Nitrogen-containing compound, and electronic element and electronic device using same SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-07-04 US disclosed
US-11691952-B2 Nitrogen-containing compound, and electronic element and electronic device using same SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-07-04 US disclosed
US-20230052660-A1 NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230052660-A1 NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME NOD1, NFE2L2, NOTCH1 MEN1 1265/4885KMT2A 1223/4885ALDH1A1 3460/4885
US-11691952-B2 Nitrogen-containing compound, and electronic element and electronic device using same NOD1, NFE2L2, NOTCH1 MEN1 1265/4885KMT2A 1223/4885ALDH1A1 3460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.